NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



First international registry of early stage breast cancer patients launched



January 13th, 2005

Aventis, part of the sanofi-aventis Group, announced the launch of A Breast Cancer Registry of Adjuvant STrategies (ABREAST), the first international prospective registry of patients with early stage breast cancer.

ABREAST will provide a current picture of "real-life" clinical practice as well as patient and disease characteristics.

This registry, using standard patient selection criteria, data collection instruments, and definitions will collect data on the treatment and outcome of 36,000 women and men, aged 18 or older, and will provide an understanding of existing and evolving practice patterns. The ABREAST project will include randomly selected...


Source: Women's Health Weekly (2005-01-13)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login